Total Payments
$2,791
2024 Payments
$1,236
Companies
23
Transactions
162
Medicare Patients
1,513
Medicare Billing
$101,809
Payment Breakdown by Category
Food & Beverage$2,791 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,791 | 162 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $483.26 | 29 | $0 (2024) |
| Novo Nordisk Inc | $478.84 | 35 | $0 (2024) |
| ABBVIE INC. | $456.01 | 23 | $0 (2024) |
| Lilly USA, LLC | $307.86 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $216.21 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $136.14 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $114.43 | 6 | $0 (2023) |
| PFIZER INC. | $110.95 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $52.70 | 3 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $45.54 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,236 | 70 | ABBVIE INC. ($367.19) |
| 2023 | $844.66 | 50 | AstraZeneca Pharmaceuticals LP ($145.42) |
| 2022 | $586.96 | 34 | AstraZeneca Pharmaceuticals LP ($125.44) |
| 2021 | $124.24 | 8 | Lilly USA, LLC ($44.79) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: VACCINES | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: Obesity | ||||||
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Cardio-renal | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: Cardiovascular | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 286 | 373 | $45,390 | $18,720 |
| 2022 | 9 | 383 | 500 | $59,635 | $29,090 |
| 2021 | 7 | 391 | 532 | $59,576 | $28,948 |
| 2020 | 11 | 453 | 613 | $61,478 | $25,051 |
Total Patients
1,513
Total Services
2,018
Medicare Billing
$101,809
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 116 | $20,880 | $7,247 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $10,080 | $7,065 | 70.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 88 | $11,000 | $3,496 | 31.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 41 | 41 | $1,640 | $565.80 | 34.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 30 | $1,350 | $157.14 | 11.6% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 11 | 15 | $330.00 | $142.80 | 43.3% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 11 | 11 | $110.00 | $47.19 | 42.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 100 | 100 | $14,000 | $10,860 | 77.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 133 | $23,585 | $9,902 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 142 | $17,280 | $6,052 | 35.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $1,815 | $1,530 | 84.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 15 | 16 | $288.00 | $205.25 | 71.3% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 20 | 21 | $462.00 | $201.59 | 43.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 41 | 41 | $1,845 | $197.54 | 10.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 19 | 19 | $190.00 | $82.66 | 43.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 17 | $170.00 | $58.51 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 95 | 95 | $13,300 | $10,492 | 78.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 195 | $23,400 | $9,288 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 109 | $19,075 | $8,409 | 44.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 61 | 61 | $2,745 | $314.24 | 11.4% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2021 | 24 | 28 | $616.00 | $271.88 | 44.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 21 | 21 | $210.00 | $91.98 | 43.8% |
| 81002 | Urinalysis, manual test | Office | 2021 | 17 | 23 | $230.00 | $80.04 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 91 | 91 | $12,740 | $8,762 | 68.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 204 | $24,480 | $8,036 | 32.8% |
About Justin Grifka
Justin Grifka is a Family healthcare provider based in Auburn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1548652860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Justin Grifka has received a total of $2,791 in payments from pharmaceutical and medical device companies, with $1,236 received in 2024. These payments were reported across 162 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,791).
As a Medicare-enrolled provider, Grifka has provided services to 1,513 Medicare beneficiaries, totaling 2,018 services with total Medicare billing of $101,809. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Auburn, MI
- Active Since 02/24/2015
- Last Updated 12/22/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548652860
Products in Payments
- VRAYLAR (Drug) $265.69
- BREZTRI (Drug) $247.25
- Kerendia (Drug) $216.21
- MOUNJARO (Drug) $200.91
- Rybelsus (Drug) $189.61
- FARXIGA (Drug) $146.12
- TRELEGY ELLIPTA (Drug) $136.14
- Ozempic (Drug) $133.48
- Wegovy (Drug) $123.61
- QULIPTA (Drug) $122.09
- SPRAVATO (Drug) $99.78
- AIRSUPRA (Drug) $89.89
- JARDIANCE (Drug) $89.70
- NURTEC ODT (Drug) $82.76
- UBRELVY (Drug) $68.23
- PREVNAR 20 (Biological) $55.93
- QUVIVIQ (Drug) $43.78
- CAPLYTA (Drug) $42.01
- TRULICITY (Drug) $41.80
- Cologuard Collection Kit (Device) $39.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Auburn
Molly Reeves
Family — Payments: $158,223
Family $158,223
Jodi Strock, Np-C, NP-C
Family — Payments: $15,991
Family $15,991
Catherine Kohl
Family — Payments: $8,838
Family $8,838
Kaylin Garnett, Crnp, Fnp-Bc, CRNP, FNP-BC
Family — Payments: $6,862
Family $6,862
Ehren Gleckler
Family — Payments: $6,853
Family $6,853
Trisha Smith, Aprn, APRN
Family — Payments: $5,011
Family $5,011